Mode
Text Size
Log in / Sign up
Phase 4 Completed N=72 Randomized Quadruple-blind Treatment

Intrathecal Morphine for Cesarean Delivery

Source: ClinicalTrials.gov NCT05069012 ↗
Enrolled (actual)
72
Serious AEs
0.0%
Results posted
Nov 2025
Primary outcomePrimary: Duration of Pain Relief — 24.5; 29.4; 32 hours
◆ Published Evidence
Emerging
13citations · ~7 / year
A randomized controlled trial of spinal morphine with an enhanced recovery pathway and its effect on duration of analgesia after cesarean delivery.
Anaesthesia, critical care & pain medicine · 2024 · Likely link

Summary

This is a randomized double blinded non-inferiority study comparing the duration of pain relief when patients receive one of three doses of spinal morphine. Enrolled patients will be randomly assigned to receive either 50 mcg, 150 mcg, or 250 mcg. All patients will receive standardized postoperative care, including multimodal analgesia. The primary outcome will be the time until the patient requests additional opioid pain medications.

Linked Publications

  • A randomized controlled trial of spinal morphine with an enhanced recovery pathway and its effect on duration of analgesia after cesarean delivery.
    Anaesthesia, critical care & pain medicine · 2024 · 13 citations · Likely link

Outcome Measures

OutcomeResultp-value
PRIMARY
Duration of Pain Relief
24.5; 29.4; 32
SECONDARY
Pain Scores
2.2; 1.8; 1.9
SECONDARY
Quality of Recovery
72; 93; 95
SECONDARY
Nausea
4.3; 8.7; 12.5
SECONDARY
Pruritus
8.7; 4.3; 4.1

Eligibility Criteria

Inclusion Criteria

  • Healthy women (ASA 2)
  • Between 18 and 45 years old
  • Singleton term pregnancies
  • Planned neuraxial anesthesia

Exclusion Criteria

  • Refusal to participate
  • Known allergy or contraindication to any medication used in the study
  • Significant medical or obstetrical disease (ASA ≥ 3)
  • Opioid use disorder
  • Chronic pain syndrome
  • Daily or near daily opioid use within last 3 weeks.
  • Patient receiving a Monoamine oxidase inhibitors (MOAi)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05069012) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search